Detalhe da pesquisa
1.
A review of the pharmacokinetics, efficacy and safety of high-purity factor X for the prophylactic treatment of hereditary factor X deficiency.
Haemophilia
; 28(4): 523-531, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499465
2.
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
N Engl J Med
; 377(23): 2215-2227, 2017 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29211678
3.
Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency.
J Thromb Haemost
; 18(10): 2551-2556, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613702